Literature DB >> 10502620

Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method.

H Murakami1, M Kobayashi, H Takeuchi, Y Kawashima.   

Abstract

PURPOSE: The objectives of this study were to establish a new preparation method for poly(DL-lactide-co-glycolide) (PLGA) nanoparticles by modifying the spontaneous emulsification solvent diffusion (SESD) method and to elucidate the mechanism of nanoparticle formation on the basis of the phase separation principle of PLGA and poly(vinyl alcohol) (PVA) in the preparation system.
METHODS: PLGA nanoparticles were prepared by the modified-SESD method using various solvent systems consisting of two water-miscible organic solvents, in which one solvent has more affinity to PLGA than to PVA and the other has more affinity to PVA than to PLGA. The yield, particle size, size distribution and PVA content of the PLGA nanoparticles were evaluated, and the phase separation behaviors of the polymers were elucidated.
RESULTS: The modified-SESD method provided a good yield of PLGA nanoparticles over a wide range of composition ratios in the binary mixture of organic solvents. Several process parameters, including the fed amount of PLGA, PLGA concentration and PVA concentration were examined to achieve the optimum preparation conditions. The discrete powder of PLGA nanoparticles was obtained by freeze-drying. No change in the PVA content of PLGA nanoparticles was observed even after several times of washing treatment by ultrafiltration, suggesting a strong surface adsorption. It was found that the appropriate selections of binary solvent mixtures and polymeric concentrations in both organic and aqueous phases could provide excellent yield and favorable physical properties of PLGA nanoparticles.
CONCLUSION: The proposed modified-SESD method can be used to provide PLGA nanoparticles of satisfactory quality at an acceptable yield for industrial purposes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502620     DOI: 10.1016/s0378-5173(99)00187-8

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  56 in total

1.  Microsphere preparation using the untoxic solvent glycofurol.

Authors:  Daniela Allhenn; Alf Lamprecht
Journal:  Pharm Res       Date:  2010-10-29       Impact factor: 4.200

2.  Pulmonary immunization of guinea pigs with diphtheria CRM-197 antigen as nanoparticle aggregate dry powders enhance local and systemic immune responses.

Authors:  Pavan Muttil; Brian Pulliam; Lucila Garcia-Contreras; John Kevin Fallon; Chenchen Wang; Anthony James Hickey; David A Edwards
Journal:  AAPS J       Date:  2010-09-28       Impact factor: 4.009

3.  Comparison of diafiltration and tangential flow filtration for purification of nanoparticle suspensions.

Authors:  Gautam Dalwadi; Heather A E Benson; Yan Chen
Journal:  Pharm Res       Date:  2005-12       Impact factor: 4.200

Review 4.  Biodegradable nanoparticles for cytosolic delivery of therapeutics.

Authors:  Jaspreet K Vasir; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2007-06-26       Impact factor: 15.470

Review 5.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

6.  pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.

Authors:  Tao Zhang; Timothy F Sturgis; Bi-Botti C Youan
Journal:  Eur J Pharm Biopharm       Date:  2011-06-26       Impact factor: 5.571

7.  PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio.

Authors:  Li Mu; Si-Shen Feng
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

8.  Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.

Authors:  Dhruba J Bharali; Murat Yalcin; Paul J Davis; Shaker A Mousa
Journal:  Nanomedicine (Lond)       Date:  2013-02-28       Impact factor: 5.307

9.  Prolonging the in vivo residence time of prostaglandin E(1) with biodegradable nanoparticles.

Authors:  Tsutomu Ishihara; Miyuki Takahashi; Megumu Higaki; Mitsuko Takenaga; Tohru Mizushima; Yutaka Mizushima
Journal:  Pharm Res       Date:  2008-02-22       Impact factor: 4.200

10.  The effect of cosolvents on the formulation of nanoparticles from low-molecular-weight poly(l)lactide.

Authors:  Leena Peltonen; Piritta Koistinen; Milja Karjalainen; Antti Häkkinen; Jouni Hirvonen
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.